ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $161,541 | -28.5% | 19,968 | +39.3% | 0.00% | -100.0% |
| Q4 2022 | $225,792 | +28.3% | 14,336 | +28.4% | 0.00% | – |
| Q3 2022 | $176,000 | +17.3% | 11,162 | +3.8% | 0.00% | – |
| Q2 2022 | $150,000 | -19.4% | 10,752 | -0.6% | 0.00% | – |
| Q1 2022 | $186,000 | -35.9% | 10,816 | -45.7% | 0.00% | -100.0% |
| Q4 2021 | $290,000 | -73.0% | 19,935 | -66.6% | 0.00% | -50.0% |
| Q3 2021 | $1,075,000 | +102.4% | 59,696 | +97.3% | 0.00% | +100.0% |
| Q2 2021 | $531,000 | +93.8% | 30,263 | +184.8% | 0.00% | – |
| Q3 2017 | $274,000 | -6.8% | 10,625 | -1.8% | 0.00% | – |
| Q2 2017 | $294,000 | – | 10,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |